2013 Russell Ross memorial lecture in vascular biology: cellular and molecular mechanisms of diabetes mellitus-accelerated atherosclerosis

scientific article published on April 2014

2013 Russell Ross memorial lecture in vascular biology: cellular and molecular mechanisms of diabetes mellitus-accelerated atherosclerosis is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1161/ATVBAHA.113.301928
P932PMC publication ID3967130
P698PubMed publication ID24665124

P50authorKarin E. BornfeldtQ87887672
P2860cites workObesity, Metabolic Syndrome, and Cardiovascular DiseaseQ22241664
Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 DiabetesQ22250887
Human aldose reductase expression accelerates diabetic atherosclerosis in transgenic miceQ24530027
Atherosclerosis — An Inflammatory DiseaseQ26776972
Vascular cellular adhesion molecule-1 (VCAM-1) expression in mice retinal vessels is affected by both hyperglycemia and hyperlipidemiaQ27320203
Inflammation determines the pro-adhesive properties of high extracellular d-glucose in human endothelial cells in vitro and rat microvessels in vivoQ27331780
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) GroupQ27860882
Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cellsQ28509783
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetesQ29547541
Effects of intensive glucose lowering in type 2 diabetesQ29547736
Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein EQ29615236
Oxidative Stress and Diabetic ComplicationsQ29615423
Glucose control and vascular complications in veterans with type 2 diabetesQ29619213
Myeloid lineage cell-restricted insulin resistance protects apolipoproteinE-deficient mice against atherosclerosisQ30412997
Accelerated atherosclerosis in Apoe-/- mice heterozygous for the insulin receptor and the insulin receptor substrate-1Q30418857
Elevated glucose and diabetes promote interleukin-12 cytokine gene expression in mouse macrophagesQ30439419
The pathogenesis of atherosclerosis (first of two parts)Q33492794
Hyperglycemia-induced reactive oxygen species increase expression of the receptor for advanced glycation end products (RAGE) and RAGE ligandsQ33556567
Bifurcation of insulin signaling pathway in rat liver: mTORC1 required for stimulation of lipogenesis, but not inhibition of gluconeogenesisQ33734679
Massive xanthomatosis and atherosclerosis in cholesterol-fed low density lipoprotein receptor-negative miceQ34142722
Atherosclerosis and the arterial smooth muscle cell: Proliferation of smooth muscle is a key event in the genesis of the lesions of atherosclerosisQ34207431
Increase in GLUT1 in Smooth Muscle Alters Vascular Contractility and Increases Inflammation in Response to Vascular InjuryQ34459819
Loss of insulin signaling in vascular endothelial cells accelerates atherosclerosis in apolipoprotein E null miceQ34485920
Diabetes adversely affects macrophages during atherosclerotic plaque regression in miceQ35043471
Monocyte trafficking in acute and chronic inflammationQ35230750
Extramedullary hematopoiesis generates Ly-6C(high) monocytes that infiltrate atherosclerotic lesionsQ35687871
Human aldose reductase expression accelerates atherosclerosis in diabetic apolipoprotein E-/- miceQ35753067
Abnormal NF-kappa B function characterizes human type 1 diabetes dendritic cells and monocytesQ46739819
Insufficient glycemic control increases nuclear factor-kappa B binding activity in peripheral blood mononuclear cells isolated from patients with type 1 diabetesQ47693425
Clustering of insulin resistance with vascular dysfunction and low-grade inflammation in type 2 diabetes.Q51501073
Molecular mechanisms of atherosclerosis in metabolic syndrome: role of reduced IRS2-dependent signaling.Q52589303
Inhibition of hypercholesterolemia-induced atherosclerosis in the nonhuman primate by probucol. II. Cellular composition and proliferation.Q54161571
Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus.Q54225577
Inflammatory stress in primary venous and aortic endothelial cells of type 1 diabetic mice.Q54433790
Macrophage insulin receptor deficiency increases ER stress-induced apoptosis and necrotic core formation in advanced atherosclerotic lesions.Q54610885
NADPH Oxidase 1 Plays a Key Role in Diabetes Mellitus–Accelerated AtherosclerosisQ56991358
Lack of the Antioxidant Enzyme Glutathione Peroxidase-1 Accelerates Atherosclerosis in Diabetic Apolipoprotein E–Deficient MiceQ59284858
Mortality from heart disease in a cohort of 23,000 patients with insulin-treated diabetesQ62583515
Two classes of PDGF receptor recognize different isoforms of PDGFQ69828348
Absence of correlation between coronary arterial atherosclerosis and severity or duration of diabetes mellitus of adult onsetQ71322456
Relation of glycohemoglobin and adiposity to atherosclerosis in youth. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research GroupQ72235731
Accelerated atherosclerosis and premature calcified cartilaginous metaplasia in the aorta of diabetic male Apo E knockout mice can be prevented by chronic treatment with 17 beta-estradiolQ78004667
Type 2 Diabetes and Lipoprotein Metabolism Affect LPS-Induced Cytokine and Chemokine Release in Primary Human MonocytesQ82589645
The Role of Toll-Like Receptors in Diabetes-Induced Inflammation: Implications for Vascular ComplicationsQ83401137
Diabetes promotes an inflammatory macrophage phenotype and atherosclerosis through acyl-CoA synthetase 1.Q35849515
Leukocytosis and ischemic vascular disease morbidity and mortality: is it time to intervene?Q36015697
Increased toll-like receptor (TLR) 2 and TLR4 expression in monocytes from patients with type 1 diabetes: further evidence of a proinflammatory stateQ36459935
Aldose reductase protects against early atherosclerotic lesion formation in apolipoprotein E-null miceQ36543639
Diabetic atherosclerosis in APOE*4 mice: synergy between lipoprotein metabolism and vascular inflammationQ36658372
Acyl-CoA synthetase 1 is induced by Gram-negative bacteria and lipopolysaccharide and is required for phospholipid turnover in stimulated macrophagesQ36742281
Loss of Akt1 leads to severe atherosclerosis and occlusive coronary artery diseaseQ36753752
Do glucose and lipids exert independent effects on atherosclerotic lesion initiation or progression to advanced plaques?Q36775094
Monocyte-directed RNAi targeting CCR2 improves infarct healing in atherosclerosis-prone miceQ36867835
Type 1 diabetes promotes disruption of advanced atherosclerotic lesions in LDL receptor-deficient mice.Q36883079
Distinct monocyte gene-expression profiles in autoimmune diabetesQ36906389
Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemiaQ36916418
Closing the loop on inflammation and atherothrombosis: why perform the CIRT and CANTOS trials?Q37026106
Monocyte-endothelial cell interactions in the development of atherosclerosisQ37116502
Local proliferation dominates lesional macrophage accumulation in atherosclerosisQ37161176
Increased atherosclerosis in streptozotocin-induced diabetic miceQ37353969
Monocytes from patients with type 1 diabetes spontaneously secrete proinflammatory cytokines inducing Th17 cellsQ37405753
A platelet-dependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitroQ37438001
Diabetes and diabetes-associated lipid abnormalities have distinct effects on initiation and progression of atherosclerotic lesionsQ37486465
Hyperglycemia promotes myelopoiesis and impairs the resolution of atherosclerosisQ37711215
Aldose reductase and cardiovascular diseases, creating human-like diabetic complications in an experimental model.Q37751655
Intraplaque haemorrhages as the trigger of plaque vulnerabilityQ37852494
Unlocking the biology of RAGE in diabetic microvascular complicationsQ38134924
TLR4 antagonist reduces early-stage atherosclerosis in diabetic apolipoprotein E-deficient mice.Q39260793
The pathogenesis of atherosclerosis (second of two parts)Q40547842
Molecular mechanisms of tumor necrosis factor alpha gene expression in monocytic cells via hyperglycemia-induced oxidant stress-dependent and -independent pathwaysQ40876050
The smooth muscle cell. II. Growth of smooth muscle in culture and formation of elastic fibersQ41141776
Diabetes and cardiovascular disease. The Framingham studyQ41509493
Diabetes mellitus accelerates cartilaginous metaplasia and calcification in atherosclerotic vessels of LDLr mutant miceQ42405231
Platelet-derived growth factor. II. Specific binding to cultured cellsQ42825333
Short-term hyperglycaemia causes non-reversible changes in arterial gene expression in a fully ‘switchable’ in vivo mouse model of diabetesQ42906142
Effects of nonlipid risk factors on atherosclerosis in youth with a favorable lipoprotein profileQ43546643
Knockout of toll-like receptor-4 attenuates the pro-inflammatory state of diabetesQ43565027
Diabetes accelerates smooth muscle accumulation in lesions of atherosclerosis: lack of direct growth-promoting effects of high glucose levelsQ43566166
Elevated ambient glucose induces acute inflammatory events in the microvasculature: effects of insulinQ43606088
Carotid artery intima-media thickness in children with type 1 diabetesQ43867572
Endothelium-dependent and -independent vascular dysfunction in type 1 diabetes: role of conventional risk factors, sex, and glycemic controlQ44417109
Morphologic findings of coronary atherosclerotic plaques in diabetics: a postmortem studyQ44895725
Effect of streptozotocin-induced hyperglycemia on lipid profiles, formation of advanced glycation endproducts in lesions, and extent of atherosclerosis in LDL receptor-deficient miceQ45120387
Hyperlipidemia in concert with hyperglycemia stimulates the proliferation of macrophages in atherosclerotic lesions: potential role of glucose-oxidized LDL.Q45161321
Activation of peripheral blood CD14+ monocytes occurs in diabetesQ46670144
P433issue4
P407language of work or nameEnglishQ1860
P921main subjectatherosclerosisQ12252367
P304page(s)705-714
P577publication date2014-04-01
P1433published inArteriosclerosis, Thrombosis, and Vascular BiologyQ4797542
P1476title2013 Russell Ross memorial lecture in vascular biology: cellular and molecular mechanisms of diabetes mellitus-accelerated atherosclerosis
P478volume34

Reverse relations

cites work (P2860)
Q57134943Activated protein C reverses epigenetically sustained p66 expression in plaque-associated macrophages in diabetes
Q39071314Arterial Calcification in Diabetes Mellitus: Preclinical Models and Translational Implications.
Q35868161Balloon Angioplasty - The Legacy of Andreas Grüntzig, M.D. (1939-1985)
Q37011769Clinical Update: Cardiovascular Disease in Diabetes Mellitus: Atherosclerotic Cardiovascular Disease and Heart Failure in Type 2 Diabetes Mellitus - Mechanisms, Management, and Clinical Considerations
Q34393408Dicarbonyl stress and atherosclerosis: is it all RAGE?
Q58571918Endothelial-Vascular Smooth Muscle Cells Interactions in Atherosclerosis
Q90650768Hyperglycaemia, ejection fraction and the risk of heart failure or cardiovascular death in patients with type 2 diabetes and a recent acute coronary syndrome
Q50541242Inflammation and myointimal hyperplasia. Correlation with hemodynamic forces.
Q36021915Morphometric and histological parameters in veins of diabetic patients undergoing brachiocephalic fistula placement
Q28081466Noncoding RNA in age-related cardiovascular diseases
Q46305214Resveratrol attenuates high glucose-induced endothelial cell apoptosis via mediation of store-operated calcium entry
Q60921126Thoracic aortic calcification across the clinical dysglycemic continuum in a large Asian population free of cardiovascular symptoms
Q35881759Uncomplicating the Macrovascular Complications of Diabetes: The 2014 Edwin Bierman Award Lecture

Search more.